Transcriptomics as an Aid in the Histological Diagnosis of Acute Rejection After Liver Transplantation
Eligible age
18+ yrs
Accepts
All genders
Locations
0 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The primary objective of this exploratory study is to identify genes associated with acute rejection in liver transplant patients. To this end, a panel of acute rejection indicator genes (both humoral and cell-mediated) will be selected from results published in the literature and applied to biological material derived from biopsies. The secodnary objective is to identify genes associated with the diagnosis of humoral acute rejection and those associated with the diagnosis of cell-mediated acute rejection.
Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna
You may qualify if…
- ✓ Patients with a diagnosis of post-OLT rejection prior to the visit at which they will be enrolled, with tissue available for RT-PCR investigations
- ✓ Age ≥ 18 years
- ✓ Informed consent
You may not qualify if…
- ✕ Age \<18 years
Source: ClinicalTrials.gov · NCT06734013 · last updated 2024-12-16